CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study.

MLA

Jiménez-Sousa, María Ángeles, et al. “CXCL9-11 Polymorphisms Are Associated with Liver Fibrosis in Patients with Chronic Hepatitis C: A Cross-Sectional Study.” Clinical and Translational Medicine, vol. 6, no. 1, Dec. 2017, p. 26. EBSCOhost, https://doi.org/10.1186/s40169-017-0156-3.

APA

Jiménez-Sousa, M. Á., Gómez-Moreno, A. Z., Pineda-Tenor, D., Medrano, L. M., Sánchez-Ruano, J. J., Fernández-Rodríguez, A., Artaza-Varasa, T., Saura-Montalban, J., Vázquez-Morón, S., Ryan, P., & Resino, S. (2017). CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study. Clinical and Translational Medicine, 6(1), 26. https://doi.org/10.1186/s40169-017-0156-3

Chicago

Jiménez-Sousa, María Ángeles, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, Luz Maria Medrano, Juan José Sánchez-Ruano, Amanda Fernández-Rodríguez, Tomas Artaza-Varasa, et al. 2017. “CXCL9-11 Polymorphisms Are Associated with Liver Fibrosis in Patients with Chronic Hepatitis C: A Cross-Sectional Study.” Clinical and Translational Medicine 6 (1): 26. doi:10.1186/s40169-017-0156-3.